Firms Not Making Progress In Improving Recall Notifications, FDA Says
This article was originally published in The Gray Sheet
More than four years after it was revealed that Guidant failed to properly warn patients and physicians about potentially fatal product malfunctions, an FDA official says the overall quality of manufacturer recall notifications has not improved
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.